Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC 46749) - Nicholson, N S; Panzer-Knodle, S G; Salyers, A K; Taite, B B; King, L W; Miyano, M; Gorczynski, R J; Williams, M H; Zupec, M E; Tjoeng, F S; Adams, S P; Feigen, L P (J Pharmacol Exp Ther, 1991)